Aurobindo Pharma Limited
Aurobindo Pharma Limited (India) holds 0 active US FDA Type II Drug Master Files and 28 inactive, has DMF or CEP filings on record for 20 active ingredients and is linked to 3 FDA-registered manufacturing sites. 43 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Aurobindo Pharma Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aurobindo-pharma-limited
Overview
Aurobindo Pharma Limited is a leading pharmaceutical company headquartered in India. It specializes in the development, manufacture, and sale of generic pharmaceutical formulations and active pharmaceutical ingredients. The company is known for its wide range of therapeutic offerings and global reach.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Aurobindo Pharma Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Aurobindo Pharma Limited holds 0 active (28 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- CLINDAMYCIN HYDROCHLORIDE USPInactive2012-04-02
- CANDESARTAN CILEXETIL (NON STERILE DRUG SUBSTANCE)Inactive2010-11-04
- FLUVASTATIN SODIUM USP (NON-STERILE DRUG SUBSTANCE)Inactive2010-04-08
- VALSARTAN USP (NON-STERILE DRUG SUBSTANCE)Inactive2008-07-30
- CEFOXITIN SODIUM USP (STERILE BULK)Inactive2008-01-31
- GLYCOPYRROLATE USP, NON-STERILE DRUG SUBSTANCEInactive2007-07-31
- CEFOXITIN ACID (NON-STERILE DRUG SUBSTANCE INTERMEDIATE)Inactive2007-02-19
- AMOXICILLIN SODIUM (STERILE) BULKInactive2006-12-30
- CEFTAZIDIME FOR INJECTION USP (STERILE BULK)Inactive2006-11-17
- CEPHALOTHIN ACID (NON-STERILE DRUG SUBSTANCE INTERMEDIATE)Inactive2006-11-16
- INDINAVIR SULFATE USP (NON-STERILE DRUG SUBSTANCE)Inactive2006-10-06
- CEFEPIME FOR INJECTION USP (STERILE BULK)Inactive2006-09-07
- CEFTAZIDIME DIHYDROCHLORIDE, NON-STERILE DRUG SUBSTANCE INTERMEDIATEInactive2006-07-28
- CEFACLOR USPInactive2006-07-26
- CEFEPIME HYDROCHLORIDE, NON-STERILE INTERMEDIATE DRUG SUBSTANCEInactive2006-05-26
- 6-AMINO PENICILLANIC ACID DRUG SUBSTANCE INTERMEDIATEInactive2006-03-31
- CEFUROXIME SODIUM (STERILE) USPInactive2005-10-01
- CEFUROXIME SODIUMInactive2005-07-15
- NELFINAVIR MESYLATEInactive2005-06-18
- CEFAZOLIN SODIUM USPInactive2005-05-21
- PENTOXIFYLLINE USPInactive2005-03-29
- CEFOTAXIME SODIUM (STERILE)Inactive2005-02-28
- LISINOPRIL USPInactive2005-02-17
- CEFTRIAXONE SODIUM (STERILE)Inactive2004-12-08
- LAMIVUDINE USPInactive2004-12-03
- CEFTRIAXONE SODIUMInactive2004-10-30
- 7-AMINO DESACETOXY CEPHALOSPORANIC ACID (7-ADCA)Inactive2004-07-05
- AMIODARONE HYDROCHLORIDEInactive2004-03-05
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to Aurobindo Pharma Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
43 FDA enforcement records linked to this company.
- 4832023-09-29
Control procedures to monitor and validate performance
- 4832023-07-21
Written procedures not established/followed
- 4832023-07-21
Following/documenting laboratory controls
- 4832023-07-21
Sanitation--buildings not clean, free of infestation
- 4832022-05-10
Equipment Design, Size and Location
- 4832022-05-10
Absence of Written Procedures
- 4832022-05-10
Written program not followed
- 4832022-05-10
Computer control of master formula records
- 4832022-05-10
Prepared for each batch, include complete information
- 4832022-05-10
Extent of discrepancy, failure investigations
- 4832019-05-24
Buildings of Suitable Size, Construction, Location
- 4832019-05-24
Procedures not in writing, fully followed
- 4832019-05-24
Complete test data included in records
- 4832019-05-24
Written record of complaint to include findings, follow-up
- 4832019-05-24
Backup data not assured as exact and complete
- 4832019-05-24
Written procedures not established/followed
- 4832019-05-24
Computer control of master formula records
- 4832019-05-24
Active ingredient retained sample kept
- 4832019-05-24
Storage conditions
- 4832019-05-24
Written record of investigation incomplete
- 4832018-08-10
Failure to develop written procedures
- 4832018-08-10
Incomplete periodic safety report
- 4832018-03-16
Complete Test Data
- 4832018-03-16
Procedures for sterile drug products
- recall — Class III2018-02-28
Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg
- recall — Class I2018-02-14
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
- 4832017-04-18
Complete test data included in records
- 4832017-04-18
Procedures not in writing, fully followed
- 4832017-04-18
Scientifically sound laboratory controls
- 4832017-04-18
Authority lacking to review records, investigate errors
- 4832017-04-18
Test methods
- 4832017-04-18
Deviations from laboratory control requirements
- recall — Class II2012-11-14
Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg
- 4832012-09-21
Approve or reject components, products
- 4832012-09-21
Cleaning / Sanitizing / Maintenance
- 4832012-09-21
Scientifically sound laboratory controls
- 4832012-09-21
Microbiological testing
- 4832012-09-21
Complaint Handling Procedure
- 4832012-09-21
Absence of Written Procedures
- 4832012-09-21
Testing and release for distribution
- 4832011-09-08
Mix-up
- warning_letter2011-05-20
FDA Warning Letter (drug product)
- 4832010-09-17
Complaint Investigation/Follow-Up Findings
Is this Aurobindo Pharma Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.